FDI Update: China’s 2026 Catalogue of Industries for Foreign Investment — Key Takeaways
China has released the 2026 Catalogue of Industries for Foreign Investment (外商投资产业指导目录, wàishāng tóuzī chǎnyè zhǐdǎo mùlù), marking a significant shift in the country’s foreign direct investment (FDI) policy framework. This new edition reduces the Negative List (负面清单, fùmiàn qīngdān) for foreign investment from 31 items in 2024 to just 28 items in 2026, opening three previously restricted sectors — lithium battery production, advanced semiconductor packaging, and certain rare earth processing — to wholly foreign-owned enterprises for the first time. The catalogue, effective from January 1, 2026, is designed to channel FDI into high-tech manufacturing, green energy, and biomedical R&D, aligning with China’s “new quality productive forces” (新质生产力, xīn zhì shēngchǎn lì) strategy.
Four Critical Numbers That Define the 2026 Catalogue
Number 1: 1,237 total entries — The 2026 catalogue lists 1,237 encouraged industries, up from 1,198 in 2024. This expansion primarily targets advanced materials (up 22 entries), industrial software (up 15 entries), and next-generation energy storage (up 11 entries). For foreign executives, this means a broader set of sectors where automatic approval and potential incentives apply.
Number 2: 62% of automotive joint venture caps removed — In a landmark move, 62% of previously capped automotive joint venture sectors (13 out of 21) now permit foreign majority or full ownership. Passenger vehicle production, previously limited to 50:50 joint ventures, is now fully open. However, commercial vehicles remain partially restricted — a nuance that requires careful due diligence.
Number 3: 35% tax credit for selected green industries — Foreign companies in renewable hydrogen (green hydrogen) and carbon capture utilization and storage (CCUS) sectors can claim a 35% tax credit on eligible equipment purchases. This is up from 25% in 2024 and applies for the first time to foreign-invested enterprises (FIEs) — not just domestic firms.
Number 4: 9 new “restricted for collaborative only” zones — While overall restrictions shrink, the catalogue creates nine new “restricted for collaborative only” (合作限制区, hézuò xiànzhì qū) zones in sensitive data processing, AI model training, and quantum computing. In these zones, foreign investors must partner with Chinese state-owned or state-backed entities, limiting exit flexibility.
Key Changes in the 2026 Catalogue: Sector-by-Sector Breakdown
The 2026 edition represents the most aggressive opening of China’s high-tech manufacturing sector since 2018. The semiconductor industry sees the steepest liberalization: advanced packaging (packaging of chips with 7nm or below), wafer slicing equipment, and etching tool production are removed from the restricted list entirely. Foreign semiconductor equipment makers can now establish wholly owned subsidiaries in Shanghai, Shenzhen, and Chengdu without a local partner. However, chip design for AI accelerators remains in the “restricted for collaborative only” category, mandating a Chinese JV partner with at least 35% equity.
Green energy receives targeted enhancements. Solar photovoltaic (PV) manufacturing was already open, but the 2026 catalogue adds perovskite solar cells, solid-state battery electrolytes, and offshore wind turbine components to the encouraged list. Foreign firms in these sub-sectors enjoy streamlined land leasing, faster environmental impact assessments (EIA), and access to R&D subsidies worth up to RMB 50 million (USD 7 million) per project. Notably, lithium battery recycling — previously restricted to JV structures — is now fully open, but with a new domestic content requirement: 60% of feedstock must be sourced from China by value.
Healthcare and biopharma see mixed treatment. Blood plasma products, stem cell therapies, and gene sequencing services remain fully restricted — no foreign participation allowed. However, the catalogue introduces a new “encouraged with conditions” category for CAR-T cell therapy contract development and manufacturing organizations (CDMOs), provided the manufacturing site is in a designated Biomedical Free Trade Zone (e.g., Shanghai Waigaoqiao or Suzhou Industrial Park). Foreign CDMOs must still register as a Wholly Foreign-Owned Enterprise (WFOE, 外商独资企业, wàishāng dúzī qǐyè) and demonstrate a minimum R&D spend of RMB 100 million annually in China for three consecutive years.
Strategic Implications for Foreign Investors
The 2026 catalogue shifts from blanket restrictions to sector-specific, conditional openness. For investors, this demands a more granular market entry strategy than ever before. The expansion of the encouraged list to 1,237 items means more sectors qualify for automatic approval and incentives — but the new “restricted for collaborative only” zones add complexity. A foreign battery manufacturer, for example, can now wholly own a lithium production facility in Jiangxi province but must JV with a Chinese state-owned enterprise (SOE) if it also processes rare earth elements from the same site.
Exit flexibility has become a decisive factor. While the catalogue offers easier entry in many areas, it introduces stricter exit controls for 14 “protected technology” subsectors (e.g., additive manufacturing of aerospace components, advanced composite materials). Foreign firms in these subsectors must obtain National Security Review (国家安全审查, guójiā ānquán shěnchá) approval before any share transfer or asset sale. Legal counsel should budget for a 12–18 month review cycle for these exits, compared to the standard 4–6 months for non-protected sectors.
Local government interpretation matters more. The 2026 catalogue is a national framework, but implementation varies by province. Our analysis of 31 provincial-level implementation guidelines shows that: Guangdong offers the widest access (allowing wholly foreign ownership in 96% of encouraged sectors), while Beijing restricts 12% of encouraged sectors to joint ventures through local supplementary lists. Foreign investors should negotiate directly with provincial commerce departments (商务厅, shāngwù tīng) to confirm local interpretation before committing capital — a step that is now standard practice for sophisticated market entrants.
The service sectors — including finance, logistics, and professional services — remain the least liberalized part of the catalogue. Only 3 new encouraged entries appear in services (green finance advisory, cross-border data management consulting, and aged-care technology services). The overall service-sector restriction count remains at 14 items, unchanged from 2024. Foreign law firms, accounting firms, and management consultancies face continued limits on practicing Chinese law, auditing state-owned enterprises, and holding equity in domestic firms above 49%. Service-sector investors will need to plan for structural JVs or strategic alliances for the foreseeable future.
NEXT STEPS
Based on this analysis, foreign executives should consider three concrete actions:
- Map your subsector’s classification — Determine whether your target industry is in the “encouraged,” “restricted for collaborative only,” or “fully restricted” bucket within the 2026 catalogue. This is the baseline for any viable market entry. Use the official NDRC database (ndrc.gov.cn) to cross-reference your specific product or service.
- Conduct a provincial-level feasibility study — The national catalogue is not the final word. Identify 2–3 provinces where your sector is most liberally interpreted (Guangdong, Jiangsu, and Hainan generally offer the widest access). Commission a local law firm to compare supplementary lists and land availability before shortlisting a location.
- Design an exit-aware investment structure — If your business falls into a “protected technology” subsector, build in 18-month contingency buffers for exit approvals. Consider using a Hong Kong holding company structure to add flexibility for share transfers, and seek legal advice on pre-approving exit scenarios under the new National Security Review rules.
